Marcus Schmidt

25PUBLICATIONS
57CO-AUTHORS
Solid tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Feb 18, 2026
Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC.

U Sahin, M Schmidt, E Derhovanessian

|Feb 13, 2025
Eribulin-Induced Peripheral Neuropathy in Locally Advanced or Metastatic Breast Cancer: Final Analysis of the Prospective Cohort IRENE Study.

Marcus Schmidt, Tobias Hesse, Oliver Hoffmann

|Jan 06, 2025
Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial.

Juanita Lopez, Thomas Powles, Fadi Braiteh

|Oct 26, 2024
Prognostic Impact of Acute and Chronic Inflammatory Interleukin Signatures in the Tumor Microenvironment of Early Breast Cancer.

Anne-Sophie Heimes, Ina Shehaj, Katrin Almstedt

|Jul 30, 2024
GAIN2 trial overall survival with intense versus tailored dose dense chemotherapy in early breast cancer.

Volker Möbus, Hans-Joachim Lück, Ekkehart Ladda

|Jun 27, 2024
<i>BRCA1</i>, <i>BRCA2</i> and <i>PALB2</i> mRNA Expression as Prognostic Markers in Patients with Early Breast Cancer.

Ina Shehaj, Slavomir Krajnak, Katrin Almstedt

Pageof 5

Frequent Collaborators

8 joint publications

Roxana Schwab

3 joint publications

Tjoung-Won Park-Simon

3 joint publications

Walburgis Brenner

2 joint publications

Ugur Sahin